Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Metadata
Title
Antidepressant drug choice for first users in two regions in the Netherlands
Authors
A.C.G. Egberts
M. Veenstra
L.T.W. de Jong - van den Berg
Publication date
01-06-1999
Publisher
Kluwer Academic Publishers
Published in
International Journal of Clinical Pharmacy / Issue 3/1999
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1023/A:1008675402004

Other articles of this Issue 3/1999

International Journal of Clinical Pharmacy 3/1999 Go to the issue

OriginalPaper

Technicians or patient advocates? − still a valid question

OriginalPaper

The quality of Dutch hospital drug formularies: Evaluation of technical features and organisational information

OriginalPaper

Proceedings – ESCP27 th European Symposium on Clinical Pharmacy Evidence-Based Pharmaceutical Care, 26-28 October 1998, Jerusalem, Israel

OriginalPaper

Long‐term stability of morphine and bupivacaine mixture for spinal use

OriginalPaper

Asthma exacerbations during first therapy with long acting β2‐agonists

OriginalPaper

The role of the French community pharmacist in drug dispensing
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits